U.S. Hospitality Stock News

The Clorox Company reported past third-quarter 2026 results with essentially flat sales at US$1,670 million and slightly higher diluted EPS of US$1.54 from continuing operations, while nine‑month sales and earnings declined versus the prior year. Alongside earnings, Clorox cut its full‑year 2026 outlook, now expecting about a 6% net sales decline and a 24% to 27% drop in diluted EPS, while also filing a shelf registration for potential debt issuance as it absorbs GOJO acquisition costs and...

Wondering if Stryker at around US$290.88 is offering value or just noise after a choppy run? This article breaks down what the current price may really imply. The stock has recently seen sharp moves, with returns of 11.6% over 7 days, 12.3% over 30 days, 16.5% year to date and 23.0% over 1 year, alongside more moderate 3.9% and 19.7% returns over 3 and 5 years. Recent coverage has focused on Stryker as a large medical equipment player, with investors weighing its long term track record...

Wondering whether Plains GP Holdings is still reasonably priced after its strong run, or if expectations have gone too far? This breakdown will help you frame the stock's current value against its fundamentals. The stock last closed at US$24.23, with returns of 3.6% over 7 days, 0.7% over 30 days, 24.8% year to date and 52.0% over the past year, plus 128.0% over 3 years and 247.1% over 5 years. Recent coverage has focused on Plains GP Holdings as an established player in the midstream energy...

LPL Financial Holdings Inc. recently reported its first-quarter 2026 results, with revenue rising to US$4.94 billion and net income to US$356.40 million, while its board approved a US$0.30 per share dividend payable on June 4 2026 to stockholders of record on May 21 2026. The quarter highlighted record earnings per share alongside organic net new assets of US$21.00 billion and continued progress on the Commonwealth integration, even as revenue and EPS came in below analyst expectations and...

Bio-Techne stock: recent performance snapshot Bio-Techne (TECH) has drawn investor attention after a mixed stretch, with a small gain over the past month alongside a decline over the past 3 months and weaker multi year total returns. Against that backdrop, the stock last closed at US$54.74, with annual revenue of US$1.22b and net income of US$81.06m. This positions the company as a mid cap player in life science tools and diagnostics. See our latest analysis for Bio-Techne. Short term...

In late April 2026, Kontoor Brands’ board approved updated bylaws clarifying virtual shareholder meetings and tightening advance notice and proxy rules, while also declaring a regular quarterly cash dividend of US$0.53 per share payable on June 18, 2026, to shareholders of record on June 8, 2026. Alongside these governance and capital-return moves, a new Chaco x Wrangler collaboration extends the Wrangler brand into outdoor footwear and apparel, highlighting how Kontoor is pairing its...

Wondering if Teva Pharmaceutical Industries at around US$35.35 is still offering value or if most of the opportunity has already been reflected in the price? This article breaks down what the current valuation signals are really saying. The stock has posted returns of 13.1% over the past week, 17.5% over the last month, 14.2% year to date and 115.7% over the past year, with a very large 3 year gain and a 244.9% 5 year return that naturally raise questions about risk and reward at today’s...

Compass (NYSE:COMP) agreed to acquire a 51% controlling stake in a venture, expanding its influence over a key part of its residential real estate platform. The company also entered a three year alliance with Rocket to broaden its home listing inventory and give agents access to a wider set of buyer and seller opportunities. At the same time, Compass continues to face federal price fixing litigation that introduces ongoing legal and operational uncertainty for the business. Compass focuses...

In April and early May 2026, Toast expanded its international footprint with the launch of its Toast Go 3 handheld POS in the UK, Ireland, Canada, and Australia, and was named a recommended POS provider for Preferred Hotels & Resorts member properties across these markets and the US. This combination of a new hotel affiliation and broader Toast Go 3 availability highlights Toast’s push into complex, multi-venue hospitality settings beyond traditional restaurants. We’ll now examine how...

H2O America stock: overview and recent performance H2O America (HTO) has drawn fresh attention after its recent name change from SJW Group in May 2025. This has prompted investors to reassess how the stock’s returns and fundamentals stack up today. The utility provider, focused on water and related services in the United States, recently closed at $57.32. Over the past month the stock shows a return of a 3.1% decline, while the past 3 months reflect an 8.8% gain and the year-to-date figure...

This article examines whether Intuit, trading at around US$406.99, is currently priced for opportunity or already reflects its strengths, and explains what the current valuation may be indicating. The stock has returned 4.4% over the last 7 days, while the 1-year return shows a 35.1% decline, which can influence how investors think about both upside potential and risk. Recent coverage has focused on how Intuit is positioning its core software platforms and product ecosystem, providing useful...

This article looks at whether Novavax, trading at around US$8.03, is attractively priced or potentially a value trap, by exploring what the current price may be implying about the stock. The stock has seen mixed returns, with a 0.5% decline over the last 7 days, a 4.3% gain over 30 days, 12.6% year to date, 28.1% over 1 year, 7.8% over 3 years and a 95.0% loss over 5 years. Recent headlines around Novavax have kept the stock in focus, particularly as investors reassess its prospects beyond...

Accenture (NYSE:ACN) has invested in conversational AI platform Netomi to expand its use of agentic AI in customer experience. The company has also broadened its AI partnership with Google Cloud to build and deploy industry specific AI agents at scale. These moves aim to embed next generation AI directly into client operations and redefine how enterprises manage customer interactions. Accenture is trading at $180.12, with the stock showing a 1.8% gain over the past week but declines of...

The United States market remained flat over the last week, yet it has seen a significant rise of 28% over the past year, with earnings expected to grow by 16% annually. In this environment, identifying high growth tech stocks involves looking for companies that demonstrate strong innovation potential and robust financial health to capitalize on these favorable conditions.

Over the last 7 days, the United States market has remained flat, yet it has seen a significant rise of 28% over the past year, with earnings projected to grow by 16% annually in the coming years. In such an environment, identifying stocks that are trading below their intrinsic value can offer potential opportunities for investors seeking to capitalize on undervaluation.

The United States market remained flat over the last week, yet it has experienced a significant 28% rise over the past 12 months with earnings projected to grow by 16% annually. In this environment, growth companies with high insider ownership can be particularly appealing as they often indicate strong confidence from those who know the business best.

The market remained flat over the last week, though it has risen 28% over the past year with earnings expected to grow by 16% annually. For investors willing to explore beyond well-known names, penny stocks—often representing smaller or newer companies—can still offer surprising value and potential for growth. In this article, we examine three penny stocks that combine financial strength with promising prospects in today's evolving market landscape.

Over the last 7 days, the United States market has remained flat, yet it is up 28% over the past year with earnings forecasted to grow by 16% annually. In this dynamic environment, identifying stocks that are not only resilient but also poised for growth can uncover potential opportunities in lesser-known companies.

Over the last 7 days, the United States market has remained flat, yet it has experienced a substantial 28% rise over the past year. In this context of expected earnings growth of 16% per annum in the coming years, identifying dividend stocks that offer consistent payouts and potential for capital appreciation becomes crucial for investors seeking stability and income.

In April 2026, Snowflake announced extensive updates to Snowflake Intelligence and Cortex Code, aiming to connect more enterprise data sources, systems, and AI models into a single environment so organizations can run AI agents directly on governed data reflecting how their businesses operate. By positioning these AI agents as a control plane for enterprise workflows and extending Cortex Code across third-party platforms like AWS Glue, Databricks, and Postgres, Snowflake is trying to embed...

Why Knife River’s latest earnings matter for shareholders Knife River (KNF) reported first quarter revenue of US$410.1 million and a net loss of US$79.2 million, a combination that often prompts investors to reassess how the stock reflects the underlying business. See our latest analysis for Knife River. The earnings update and the recent disclosure that Vanguard Capital Management holds 5.25% of Knife River appear to sit alongside strong recent momentum, with a 30 day share price return of...

Herc Holdings Inc. has already reported first-quarter 2026 results, with sales rising to US$981 million and total revenue to US$1.14 billion, while net loss widened to US$24 million as the company completed integrating H&E Equipment Services and expanded its branch network by 30%. Alongside double-digit specialty revenue growth, record e-commerce revenue, insider share purchases and continued analyst support highlight growing confidence in Herc’s ability to capture benefits from its enlarged...

Ultra Clean Holdings recently reported first-quarter 2026 results, with revenue rising to US$533.7 million while posting a net loss of US$17.9 million, and concurrently announced the upcoming retirement of CFO Sheri Savage alongside a change in board chair later this month. The company also issued second-quarter guidance calling for higher revenue and a return to GAAP profitability and disclosed new insider trading plans and a Form 144 filing, adding fresh context to its capital structure...

Immunome has submitted a New Drug Application to the FDA for varegacestat, an oral once-daily gamma secretase inhibitor for adults with desmoid tumors, backed by a global Phase 3 RINGSIDE trial that met its primary and key secondary endpoints. A key insight is that RINGSIDE is the largest randomized study conducted in this rare tumor type, with data selected for oral presentation at the 2026 ASCO Annual Meeting, highlighting the clinical community’s interest in varegacestat’s profile. We’ll...